Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

Corbacioglu, Selim; Lode, Holger; Ellinger, Susanne; Zeman, Florian; Suttorp, Meinolf; Escherich, Gabriele; Bochennek, Konrad; Gruhn, Bernd; Lang, Peter; Rohde, Marius; Debatin, Klaus Michael; Steinbach, Daniel; Beilken, Andreas; Ladenstein, Ruth; Spachtholz, Rainer; Heiss, Peter; Hellwig, Dirk; Troeger, Anja; Koller, Michael; Menhart, Karin; Riemenschneider, Markus J.; Zoubaa, Saida; Kietz, Silke; Jakob, Marcus; Sommer, Gunhild; Heise, Tilman; Hundsdoerfer, Patrick; Kuehnle, Ingrid; Dilloo, Dagmar; Schoenberger, Stefan; Schwabe, Georg; von Luettichau, Irene; Graf, Norbert; Schlegel, Paul-Gerhardt; Fruehwald, Michael; Jorch, Norbert; Paulussen, Michael; Schneider, Dominik T.; Metzler, Markus; Leipold, Alfred; Nathrath, Michaela; Imschweiler, Thomas; Christiansen, Holger; Schmid, Irene; Crazzolara, Roman; Niktoreh, Naghmeh; Cario, Gunnar; Faber, Joerg; Demmert, Martin; Babor, Florian; Froehlich, Birgit; Bielack, Stefan; Bernig, Toralf; Greil, Johann; Eggert, Angelika; Simon, Thorsten; Foell, Juergen

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

Autor(en):

Corbacioglu, Selim; Lode, Holger; Ellinger, Susanne; Zeman, Florian; Suttorp, Meinolf; Escherich, Gabriele; Bochennek, Konrad; Gruhn, Bernd; Lang, Peter; Rohde, Marius; Debatin, Klaus Michael; Steinbach, Daniel; Beilken, Andreas; Ladenstein, Ruth; Spachtholz, Rainer; Heiss, Peter; Hellwig, Dirk; Troeger, Anja; Koller, Michael; Menhart, Karin; Riemenschneider, Markus J.; Zoubaa, Saida; Kietz, Silke; Jakob, Marcus; Sommer, Gunhild; Heise, Tilman; Hundsdoerfer, Patrick; Kuehnle, Ingrid; Dilloo, Dagmar; Schoenberger, Stefan; Schwabe, Georg; von Luettichau, Irene; Graf, Norbert; Schlegel, Paul-Gerhardt; Fruehwald, Michael; Jorch, Norbert; Paulussen, Michael; Schneider, Dominik T.; Metzler, Markus; Leipold, Alfred; Nathrath, Michaela; Imschweiler, Thomas; Christiansen, Holger; Schmid, Irene; Crazzolara, Roman; Niktoreh, Naghmeh; Cario, Gunnar; Faber, Joerg; Demmert, Martin; Babor, Florian; Froehlich, Birgit; Bielack, Stefan; Bernig, Toralf; Greil, Johann; Eggert, Angelika; Simon, Thorsten; Foell, Juergen

Tübinger Autor(en):

Lang, Peter

Erschienen in:

Lancet Oncology (2024), Bd. 25, H. 7, S. 922-932

Verlagsangabe:

New York : Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/s1470-2045(24)00202-x

ISSN:

1470-2045